baber/WOPTO huggingface dataset:
Patent AU-2002336124-B2 (AU)
Title: Biologically active peptides and their use for repairing injured nerves
Inventor: LIESI PAIVI
IPC: A61P25/00
Filed: 2002-10-25
Granted: 2008-07-03
Abstract: The present invention relates to biologically active peptides derived from the neurite outgrowth-promoting domain of laminin-1, i.e. the γ1-chain of laminin-1. These peptides include the decapeptide RDIAEIIKDI (SEQ ID NO: 1) and the truncated peptides derived therefrom comprising the biologically active domain thereof, the tripeptide KDI. The invention is directed to the biologically active tripeptide motif KDI, and to its use in promoting regeneration of neuronal or non-neuronal tissues and, in specific, to its use in the treatment of spinal cord injuries.
Patent AU-2002340628-B2 (AU)
Title: Clamp
Inventor: CASTELLANOS PETER
IPC: F16L33/08
Filed: 2002-11-11
Granted: 2008-07-31
Abstract: An article clamp ( 10 ) of the band type including an elongated flexible band ( 11 ) having on one side a plurality of spaced teeth ( 20 ) and a head ( 14 ) having a chamber ( 22 ) for receiving screw ( 23 ) for cooperation with the teeth ( 20 ) on the band ( 11 ), a proximal end ( 12 ) of the band ( 11 ) being connected to the proximal end ( 15 ) only of the head ( 14 ) such that the distal end ( 16 ) of the head ( 14 ) is spaced from and free of the band ( 11 ), the head ( 14 ) further having a passage ( 30 ) therethrough for receiving a distal end ( 13 ) of the band ( 11 ) to form the band ( 11 ) into a loop.
Patent AU-2002342568-B2 (AU)
Title: Composition and method for increasing cell density in cell cultures infected with lentivirus
Inventor: THOMAS ANNE CHRISTINE
IPC: C12N7/01
Filed: 2002-05-03
Granted: 2007-11-01
Abstract: A composition and method for enhancing cell growth and increasing the density of cell cultures containing lentivirus-infected host cells comprises adding a suitable quantity of an antibiotic to the culture to destroy harmful bacteria.
Patent AU-2002362747-B2 (AU)
Title: Decontamination of surfaces contaminated with prion- infected material with oxidizing agent-based formulations
Inventor: KAISER HERBERT J
IPC: C11D3/04
Filed: 2002-10-04
Granted: 2007-11-08
Abstract: A surface which carries a material which is infected with prions is cleaned with an alkaline cleaning solution to remove as much proteinaceous material as possible from the surface. The cleaning agent is an alkaline cleaning agent which attacks prions remaining on the surface and which attacks prions removed from the surface during the cleaning step. After the cleaning solution is drained, a solution of surfactants, buffers, and heavy metal free corrosion inhibitors is circulated over the surface at 50°-60° C. The surfactants disperse and unclump the prion-contaminated material. A strong oxidant, preferably peracetic acid, is added to the solution to bring the peracetic acid concentration to 1,000-2,500 ppm. The peracetic acid or other strong oxidant attacks the prions, particularly the unclumped prion strands, deactivating the prions. After rinsing and drying, the surface may be wrapped in a microbe impermeable barrier and subjected to terminal sterilization, such as steam autoclaving.
Patent AU-2003276214-B2 (AU)
Title: 9a-azalides with anti-inflammatory activity
Inventor: MORAZZONI GABRIELE
IPC: A61P29/00
Filed: 2003-10-28
Granted: 2009-05-28
Abstract: Macrolides with anti-inflammatory activity are described. Particularly described are 9a-azalides and their anti-inflammatory activity without cladinose in position 3, the pharmaceutically acceptable salts thereof and the pharmaceutical composition that contain them as active principle.
Patent AU-2003282276-B2 (AU)
Title: Keg with an inner bag
Inventor: ANDERSON IAN
IPC: B67D1/04
Filed: 2003-11-25
Granted: 2009-07-02
Abstract: An interlocking collar (72) secures a bag neck (46) in a keg aperture (42) of an alcohol beverage keg container (22). The interlocking collar is mounted in press fit surrounding relation with a peripheral wall portion of the bag neck. The collar has an outer peripheral wall portion sized larger than that of a keg aperture. The collar (72) has a recessed groove (76) in the collar outer peripheral wall portion for receiving in press fitting and sealing relation a keg flange (40) that defines the keg aperture. The collar outer peripheral wall portion has a resilient edge portion (78) adjacent the recessed groove that deflects to permit the interlocking collar to pass through the keg aperture and receive the keg flange in the recessed groove. The interlocking collar has a plurality of locking passageways (80) placed around the interlocking collar and axially extending through the interlocking collar between the neck and recessed groove. A latch member (82) has a plurality of locking fingers (84) that extend axially through the locking passageways to prevent deflection of the resilient edge portion of the interlocking collar after the collar is placed in the keg aperture.
Patent AU-2003287769-B2 (AU)
Title: Detector assembly suited to smoke alarms
Inventor: KELLY NEALE TERRENS
IPC: G08B29/18
Filed: 2003-12-18
Granted: 2008-05-29
Abstract: A detector assembly (10) powered by mains electricity and an elongate backup battery (76) is disclosed. The assembly includes: a ceiling mountable base (10) having a body defining a downwardly opening socket (24); a detector module (20) having a battery support portion (75) for holding the battery (76) in a vertical orientation, the module (20) receivable by the socket (24); a quick connection means for mechanically and electrically connecting the module (20) to the base (10); and shutter (50) mounted to the base (10). The shutter (50) prevents operation of the quick connection means when no vertical battery (76) is installed within the module (20). The quick connection means comprises co-operable pairs of conductors. The conductor pairs transmit power from the base (10) to the module (20). The pairs of conductors each comprise a stud conductor mounted to the base (10) and a forked conductor mounted to the module (20).
Patent AU-2003298873-B2 (AU)
Title: Methods for the identification, assessment, and treatment of patients with proteasome inhibition therapy
Inventor: MORRISSEY MICHAEL P
IPC: C07K14/47
Filed: 2003-12-04
Granted: 2011-09-01
Abstract: The present invention is directed to the identification of markers that can be used to determine whether patients with cancer are clinically responsive or non-responsive to a therapeutic regimen prior to treatment. In particular, the present invention is directed to the use of certain combinations of markers, wherein the expression of the markers correlates with responsiveness or non-responsiveness to a therapeutic regimen comprising proteasome inhibition. Thus, by examining the expression levels of individual markers and those comprising a marker set, it is possible to determine whether a therapeutic agent, or combination of agents, will be most likely to reduce the growth rate of tumors in a clinical setting.
Patent AU-2004241840-B2 (AU)
Title: Transfusion preparation for peripheral intravenous administration and method of stabilizing vitamin B1
Inventor: SUMIYOSHI NOBUAKI
IPC: A61P3/02
Filed: 2004-05-14
Granted: 2010-02-25
Abstract: The infusion preparation for peripheral parenteral administration comprises an infusion (A) containing glucose with 80 to 200 g/L concentration, and an infusion (B) containing amino acid with 50 to 150 g/L concentration. The infusion (A) and the infusion (B) are separately put into a vessel that is divided with an openable partition means. The infusion (A) does not contain sulfite, has titratable acidity of 1 or less, contains vitamin B1 and is adjusted to pH 3 to 5. The infusion (B) is adjusted to pH 6.5 to 8. After mixing the both infusions, the mixture has pH 6 to 7.5 and titratable acidity of 5 to 10.
Patent AU-2004243633-B2 (AU)
Title: Composition for the protection of glassware in a dishwashing process
Inventor: HAHN KARLHEINZ ULRICH GERHARD
IPC: C11D3/00
Filed: 2004-05-19
Granted: 2009-07-16
Abstract: The present invention provides an automatic dishwashing detergent composition comprising zinc and bismuth. It also provides a method of automatic dishwashing using a detergent composition comprising zinc and bismuth.
Patent AU-2004285316-B2 (AU)
Title: Pharmaceutical compositions based on idazoxan salt or one of the polymorphs thereof
Inventor: BOUGARET JOEL
IPC: A61K31/7012
Filed: 2004-10-28
Granted: 2010-08-19
Abstract: A pharmaceutical composition comprises (%) an idazoxan salt or idazoxan hydrate (5-20), microcrystalline cellulose (10-40), lubricant (1-5), colloidal silica (0.1-0.5) and lactose (29.5-84.8). Independent claims are included for the following: (a) tablets comprising the pharmaceutical composition (50 - 1000, preferably 100 - 600) mg; (b) manufacture of the tablet involving direct tabletting of a powder mixture; (c) use of the composition and tablet optionally in combination with an atypical antipsychotic neuroleptic exhibiting a greater antagonist affinity for the dopamine D2 receptor than is its antagonist affinity for the alpha -adrenoreceptor, a medicament for the preventive and/or curative treatment of severe psychotic disorders (preferably schizophrenia and schizoaffective disorders); (d) polymorphic forms I, II, III, IV or V of idazoxan having X-ray diffraction pattern as given in the specification and having a differential thermal analysis thermogram exhibiting a single maximum value at 207.5+-0.2, 203+-0.4, 203.8+-0.5, 205.3+-0.5, 205.6+-0.4 respectively. ACTIVITY : Antidepressant; Antiparkinsonian; Neuroleptic; CNS-Gen.. MECHANISM OF ACTION : None given.
Patent AU-2005272054-B2 (AU)
Title: Surgical sagittal saw and blade assembly for same
Inventor: CANONACO ALESSANDRO F
IPC: A61B17/14
Filed: 2005-06-30
Granted: 2012-01-19
Abstract: A surgical sagittal saw including a handpiece from which a planar guide bar extends. A saw blade is mounted to the distal end of the guide bar to move across the guide bar. Drive rods connect the saw blade to a drive assembly in the handpiece, which drive assembly reciprocates the drive rods. The drive rods oscillate the saw blade across the distal end of the guide bar. The saw is used with a cutting guide that is in a fixed position relative to the bone or hard tissue to be cut. A capture element is disposed adjacent the guide surface and holds the guide bar to the guide surface so the cut is made along the desired cut plane.
Patent AU-2005322410-B2 (AU)
Title: Antibodies directed to GPNMB and uses thereof
Inventor: LUCA RASTELLI
IPC: C12N15/63
Filed: 2005-11-30
Granted: 2011-11-10
Abstract: The present invention provides fully human monoclonal antibodies that specifically bind to GPNMB, and uses thereof. Nucleotide sequences encoding, and amino acid sequences comprising, heavy and light chain immunoglobulin molecules, particularly sequences corresponding to contiguous heavy and light chain sequences spanning the framework regions and/or complementarity determining regions (CDRs) are provided. The present invention also provides immunoconjugates comprising anti-GPNMB antibodies and methods of using such immunoconjugates. The present invention further provides bispecific antibodies comprising an anti-GPNMB antibody component and an anti-CD3 component, and methods of using such bispecific antibodies.
Patent AU-2005322839-B2 (AU)
Title: Silver/water, silver gels and silver-based compositions; and methods for making and using the same
Inventor: MOELLER WILLIAM
IPC: A61K33/243
Filed: 2005-12-30
Granted: 2012-03-29
Abstract: We disclose a colorless composition comprising metal particles (e.g., silver nanoparticles) and water, wherein said particles comprise an interior of elemental metal (e.g., silver) and an exterior of metal oxide (e.g., one or more silver oxide(s)), wherein the metal nanoparticles are present in the water at a level of about 5-40 ppm, and wherein the composition manifests significant antimicrobial properties. Methods of use of the composition are described. The composition can be incorporated into a hydrogel with essentially no loss of antimicrobial properties. Various metal-containing compositions with unexpected biological efficacy are also disclosed.
Patent AU-2006201963-B2 (AU)
Title: A pump assembly
Inventor: HENDRIKUS VAASSEN
IPC: E03B7/07
Filed: 2006-05-11
Granted: 2011-07-14
Abstract: A PUMP ASSEMBLY Abstract There is disclosed herein a pump assembly (1) including a first duct means (5) having an inlet (10) for connection to a mains water supply line (15) and an outlet (20) to 5 deliver mains water to a user. A second duct means (25) has an inlet (30) for connection to a water storage reservoir (35) and an outlet (40) to deliver stored water to the outlet (20) of the first duct means (5). Control means (45) operatively associated with the first and second duct means (5, 25) and the reservoir (35), monitors and regulates the flow of the mains and stored water delivered through the outlet (20) to the user. First duct means 10 (5) includes a valve (50) electrically operable by the control means (45) to regulate flow of mains water though the outlet (20). The second duct means (25) includes a flow control apparatus (50) to sense pressure within the second duct means (25) so that the control means (45) can determine when to energize the valve of the first duct means (5). -A'4i
Patent AU-2006213591-B2 (AU)
Title: Continuous automated rack loader
Inventor: PINTO ROBERT
IPC: A22C13/02
Filed: 2006-02-10
Granted: 2012-05-17
Abstract: An apparatus for automatically delivering raw sausages to a smokehouse rack is described. A continuous rotating conveyor holds a plurality of half-tubular trays hung on gimbals. Sausages are extruded into a tray at a loading station, and the tray is carried around by the conveyor to an unloading station, where an arm causes the tray to tilt and to roll the sausage onto a smokehouse rack.
Patent AU-2006215300-B2 (AU)
Title: Bisphosphonates for treating endometriosis
Inventor: SCHACHTER MOREY
IPC: A61K31/663
Filed: 2006-02-16
Granted: 2009-08-20
Abstract: A novel method of treating endometriosis is disclosed. The method comprises administering to a female subject in need thereof a therapeutically effective amount of particles comprising an agent capable of inhibiting phagocytic cells of the female subject.
Patent AU-2006251562-B2 (AU)
Title: Compositions containing PUFA and methods of use thereof
Inventor: WURTMAN RICHARD J
IPC: A61P25/28
Filed: 2006-05-23
Granted: 2012-03-22
Abstract: This invention provides methods of increasing or enhancing the synthesis and levels of phospholipids, synapses, synaptic proteins, and synaptic membranes by a neural cell or brain cell; methods of treating a subject with a memory disorder, memory impairment, neurological disorder, or brain disease or disorder, comprising administering to the subject a composition comprising an omega-3 fatty acid, an omega-6 fatty acid, uridine, a metabolic precursor thereof, or a combination thereof.
Patent AU-2006294546-B2 (AU)
Title: High oleic imidazolinone resistant sunflower
Inventor: GERDES JAMES T
IPC: A01H5/10
Filed: 2006-09-28
Granted: 2012-08-09
Abstract: A sunflower seed having imidazolinone resistance and an oleic acid content of greater than 85 percent is provided. Sunflower cultivars designated E83329, Ol 1601 A, OI2653R, and Ol 1601 B and having high oleic acid and imidazolinone resistance, plants and seeds of the E83329, OI1601A, OI2653R, and Ol 1601 B sunflower cultivars, methods for producing a sunflower plant produced by crossing the E83329, Ol 1601 A, OI2653R, or Ol 1601 B cultivar with itself or with another sunflower plant, and hybrid sunflower seeds and plants produced by crossing the E83329, Ol 1601 A, OI2653R, or Ol 1601 B cultivar with another sunflower line or plant are also provided.
Patent AU-2006310525-B2 (AU)
Title: Mortar composition, method for the production thereof and its use
Inventor: LAUDET ALAIN
IPC: C04B24/36
Filed: 2006-11-02
Granted: 2012-02-02
Abstract: The invention relates to a mortar composition in the form of a dry powder and ready to use, comprising at least one powdery binder and at least one aggregate as well as optionally one common additive and/or admixture and formed of particles of which at least a fine-particle portion is likely to produce a dust emission, characterized in that it also comprises a fluid additive comprised of at least one apolar bituminous organic substance and which has a power to agglomerate these fine particles formed by the fluid additive.
Patent AU-2006332138-B2 (AU)
Title: Interleukin-12p40 variants with improved stability
Inventor: LO KIN-MING
IPC: C12N5/00
Filed: 2006-12-20
Granted: 2012-03-22
Abstract: Modified interleukin-12 (IL-12) p40 polypeptides are disclosed. The modified polypeptides have alterations in the IL-12p40 subunit to eliminate the protease site between positions Lys260 and Arg261. The modified IL-12p40 polypeptides according to the invention have improved stability compared to wild-type mature human IL-12p40 polypeptides.
Patent AU-2007211119-B2 (AU)
Title: Method and apparatus for controlling an output voltage in a power amplifier
Inventor: FREI JEFFREY A
IPC: H03F3/04
Filed: 2007-01-23
Granted: 2011-10-20
Abstract: Power amplifier (PA) apparatus (300) that includes: a PA device (302) operating at a fundamental frequency and having a maximum operating frequency that is higher than the fundamental frequency, an output current having a fundamental component at the fundamental frequency and a plurality of harmonic components at different harmonic frequencies of the fundamental frequency, and an output voltage based on the output current; a first matching circuit (310) coupled to the PA device and corresponding to the fundamental component; and a second matching circuit (320) coupled between the PA device and the first matching circuit and corresponding to at least one of the harmonic components, wherein the first and second matching circuits maintain the PA output voltage at a value that is no more than a predetermined maximum value, which is less than a breakdown voltage for the PA device.
Patent AU-2007240797-B2 (AU)
Title: Purification processes for isolating purified vesicular stomatitis virus from cell culture
Inventor: CUTLER MARK WILLIAM
IPC: C12N7/02
Filed: 2007-04-19
Granted: 2013-05-23
Abstract: Novel purification processes for obtaining vesicular stomatitis virus (VSV) of improved purity from mammalian cell culture are described herein. More particularly, in certain embodiments, a process is described for purifying VSV from cell culture fluid of a mammalian cell culture infected with VSV, the process comprising: clarifying the cell culture fluid by low-speed centrifugation and recovering the VSV in the supernatant; filtering the supernatant through a 0.2 to 0.45 µm filter and recovering the VSV in the filtered solution; loading the VSV filtered solution onto a anion exchange membrane adsorber equilibrated with a first pH buffered salt solution, eluting the VSV from the anion exchange membrane adsorber with a second pH buffered salt solution and recovering the eluted VSV fractions; purifying the recovered VSV by tangential flow filtration (TFF) using a TFF membrane having a molecular weight cutoff between 300 kDa and 1,000 kDa and recovering the VSV in the retentate, and filtering the VSV retentate through a 0.2 to 0.22 µm filter and recovering the VSV in the filtered solution.
Patent AU-2007264418-B2 (AU)
Title: Methods for the preparation of biologically active compounds in nanoparticulate form
Inventor: CAMMARANO RAFFAELE
IPC: A61P19/10
Filed: 2007-06-29
Granted: 2012-05-03
Abstract: A method for producing a composition comprising nanoparticles of a biologically active compound.
Patent AU-2007312538-B2 (AU)
Title: Rspondins as modulators of angiogenesis and vasculogenesis
Inventor: KAZANSKAYA OLGA
IPC: A61K38/17
Filed: 2007-10-19
Granted: 2012-10-04
Abstract: The present invention relates to the use of Rspondins, particularly Rspondin2 (Rspo2) or Rspondin3 (Rspo3) or Rspondin nucleic acids, or regulators or effectors or modulators of Rspondin e.g. Rspo2 and/or Rspo3 to promote or inhibit angiogenesis and/or vasculogenesis, respectively. The invention is based on the demonstration that Rspo3 and Rspo2 are angiogenesis promoters, and the identification of Rspo2 and 3 as positive regulators of vascular endothelial growth factor (VEGF). These results indicate a major role for Rspondins, particularly Rspo3 and/or Rspo2 in the signalling system during angiogenesis. The invention also relates to the use regulators or effectors or modulators of Rspondin3, including agonists and antagonists, in the treatment of conditions where treatment involves inhibiting or promoting angiogenesis and/or vasculogenesis.
Patent AU-2007317057-B2 (AU)
Title: A collapsible bathtub
Inventor: BARBA KIM
IPC: A47K3/06
Filed: 2007-11-07
Granted: 2013-08-01
Abstract: A collapsible bathtub (101) comprising bottom (102) and side walls (103) made of plastic, wherein the bathtub comprises at least one flexible bendable joint (104) around which flexible bendable joint at least a part of said bottom and/or side walls are folded such that said bathtub has a collapsed position, wherein at least a part of said bendable joint is made of a flexible plastic material being more flexible than the remaining part of said bathtub.
Patent AU-2007320778-B2 (AU)
Title: Verification of a transactor's identity
Inventor: BELAMANT SERGE CHRISTIAN PIERRE
IPC: G07F7/10
Filed: 2007-11-15
Granted: 2012-09-13
Abstract: A system for facilitating a financial transaction between a prospective transactor and a transactee has an identity and account verifying facility for verifying the identity of the prospective transactor and an account that the prospective transactor has with a financial institution, the identity and account verifying facility being operated by an independent verifier. The identity and account verifying facility includes a storage means for storing an identifier of the prospective transactor and details of at least one account held by the transactor at the financial institution. An identifier input means is provided whereby the transactor enters his identifier when he subscribes to the service. An account details obtaining means for obtaining details of the transactor's account with the financial institution, an identifier input means whereby the transactor enters his identifier; and a communicating means for communicating with the independent verifier are located at the transactee, for furnishing the account details and the identifier to the verifier and for receiving a verification confirmation or rejection from the verifier, prior to the transactor conducting the financial transaction with the transactee.
Patent AU-2007324080-B2 (AU)
Title: Method and system for using payment history for conducting commercial transactions
Inventor: SWACKHAMMER CRAIG
IPC: G06F17/00
Filed: 2007-10-24
Granted: 2012-08-23
Abstract: A method is disclosed. The method includes receiving transaction data relating to a plurality of commercial transactions conducted by a plurality of buyers and sellers conducting commercial transactions using a transaction processing system, and then receiving a request for transaction information relating to the received transaction data from an entity, wherein the transaction information also relates to a commercial transaction between a buyer and a seller. The method further includes providing the transaction information to an entity, wherein the entity thereafter makes a decision about further interacting with the buyer or the seller.
Patent AU-2008201937-B2 (AU)
Title: Biosynthetic genes for butenyl-spinosyn insecticide production
Inventor: BULLARD BRIAN S
IPC: C12N1/21
Filed: 2008-05-02
Granted: 2012-08-16
Abstract: The present invention relates generally to butenyl-spinosyn biosynthetic genes, spinosyn producing microorganisms transformed with the biosynthetic genes, methods using the biosynthetic genes to increase production of butenyl-spinosyn insecticidal macrolides, and methods using the genes or fragments thereof to change the products produced by spinosyn-producing microorganisms.